gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity
- PMID: 38443447
- PMCID: PMC11061181
- DOI: 10.1038/s41423-024-01144-y
gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity
Abstract
Apart from mediating viral entry, the function of the free HIV-1 envelope protein (gp120) has yet to be elucidated. Our group previously showed that EP2 derived from one β-strand in gp120 can form amyloid fibrils that increase HIV-1 infectivity. Importantly, gp120 contains ~30 β-strands. We examined whether gp120 might serve as a precursor protein for the proteolytic release of amyloidogenic fragments that form amyloid fibrils, thereby promoting viral infection. Peptide array scanning, enzyme degradation assays, and viral infection experiments in vitro confirmed that many β-stranded peptides derived from gp120 can indeed form amyloid fibrils that increase HIV-1 infectivity. These gp120-derived amyloidogenic peptides, or GAPs, which were confirmed to form amyloid fibrils, were termed gp120-derived enhancers of viral infection (GEVIs). GEVIs specifically capture HIV-1 virions and promote their attachment to target cells, thereby increasing HIV-1 infectivity. Different GAPs can cross-interact to form heterogeneous fibrils that retain the ability to increase HIV-1 infectivity. GEVIs even suppressed the antiviral activity of a panel of antiretroviral agents. Notably, endogenous GAPs and GEVIs were found in the lymphatic fluid, lymph nodes, and cerebrospinal fluid (CSF) of AIDS patients in vivo. Overall, gp120-derived amyloid fibrils might play a crucial role in the process of HIV-1 infectivity and thus represent novel targets for anti-HIV therapeutics.
Keywords: Amyloid fibril; Enhancement of viral infectivity; HIV-1; gp120.
© 2024. The Author(s), under exclusive licence to CSI and USTC.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.PLoS One. 2015 Dec 14;10(12):e0144522. doi: 10.1371/journal.pone.0144522. eCollection 2015. PLoS One. 2015. PMID: 26656730 Free PMC article.
-
Peptides derived from HIV-1 gp120 co-receptor binding domain form amyloid fibrils and enhance HIV-1 infection.FEBS Lett. 2014 May 2;588(9):1515-22. doi: 10.1016/j.febslet.2014.03.016. Epub 2014 Mar 18. FEBS Lett. 2014. PMID: 24657436
-
The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.J Virol. 2019 Mar 21;93(7):e02128-18. doi: 10.1128/JVI.02128-18. Print 2019 Apr 1. J Virol. 2019. PMID: 30651369 Free PMC article.
-
Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.Acc Chem Res. 2017 Sep 19;50(9):2159-2166. doi: 10.1021/acs.accounts.7b00154. Epub 2017 Aug 15. Acc Chem Res. 2017. PMID: 28809479 Review.
-
Viral amyloids: New opportunities for antiviral therapeutic strategies.Curr Opin Struct Biol. 2023 Dec;83:102706. doi: 10.1016/j.sbi.2023.102706. Epub 2023 Sep 30. Curr Opin Struct Biol. 2023. PMID: 37783197 Review.
References
-
- Ronaldson PT, Bendayan R. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharm. 2006;70:1087–98. - PubMed
-
- Cossarizza A. Apoptosis and HIV infection: about molecules and genes. Curr Pharm Des. 2008;14:237–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 82073898/National Natural Science Foundation of China (National Science Foundation of China)
- 31370781/National Natural Science Foundation of China (National Science Foundation of China)
- 82072276/National Natural Science Foundation of China (National Science Foundation of China)
- 81772194/National Natural Science Foundation of China (National Science Foundation of China)
- 81630090/National Natural Science Foundation of China (National Science Foundation of China)
LinkOut - more resources
Full Text Sources
Medical